期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

幽门螺杆菌耐药研究进展 被引量：1

下载PDF
导出
摘要 目的 了解国内外幽门螺杆菌(HP)耐药的研究进展状况.方法 综合国内外HP耐药研究文献,分析HP的耐药特点、产生耐药的分子机理及避免HP耐药的策略.结果 不同国家和地区分离出的HP菌株对咪唑类、大环内酯类、β-内酰胺类均已产生不同程度的耐药,耐药菌株的产生可能与其自发突变或其遗传信息的传递有关.结论 采用规范化治疗、严格掌握HP根除治疗的适应症及联合应用抗生素与铋剂或PPI将会避免HP耐药菌株的产生.
作者 张玲霞 张沥 张欣 庄坤
机构地区 西安市中心医院消化科
出处 《中外医疗》 2007年第24期7-9,共3页 China & Foreign Medical Treatment
关键词 幽门螺杆菌 耐药
分类号 R91 [医药卫生—药学]
  • 相关文献

参考文献24

  • 1[1]Williamson JS.Helicobacter pylori:current chemotherapy and new targets for drug design[J].Curr Pharm Des,2001,7(5):355～392.
  • 2苏兆亮,许化溪,邵世和.幽门螺杆菌耐药的分子机制及检测方法研究进展[J].新医学,2005,36(6):365-367. 被引量：4
  • 3[3]McMahon BJ,Hennessy TW,Bensler JM,et al.The relationship among previous antimicrobial use,antimicrobial resistauce,and treatment outcomes for Helicobacter pylori infections[J].Ann Intem Med,2003,139(6):463～469.
  • 4[4]Megraud Francis.Epidemilolgy and mechanism of antibiotic resistance in helicobacter pylori.Gastroenterology[J].1998,115(5):1278～1282.
  • 5史彤,刘文忠,萧树东,徐蔚文.上海地区幽门螺杆菌对抗生素耐药率的变迁[J].中华内科杂志,2000,39(8):576-576. 被引量：131
  • 6[6]Toracchio S,Marzio L.Primary and secondary antibiotic resistance of Heilicobacter pylori strains isolated in central Italy during the years 1998～2002[J].Dig Liver Dis,2003,35(8):541～545.
  • 7[7]O' Morain C,Montague S.Challenges to therapy in the fulure[J].Helicobacter,2000,5(1):23～26.
  • 8[8]Tangmankongworakoon N,Mahachai V,Thong-Ngam D,et al.Patter of drug resistant Helicobacter pylori in dyspeptic patients in Thailand[J].J Med Assoc Thai,2003,86(2):439～444.
  • 9张晓光,胡品津,李瑜元,陈为,刘长秀,彭仲生,谭锦涛.广东城乡病人中分离的幽门螺杆菌对常用3种抗菌药物耐药的调查[J].新医学,2002,33(5):275-277. 被引量：37
  • 10[10]Meyer JM,Silliman NP,wang W,et al.Risk factors for Helicobacter pylori resistance in the United Sates:the surveillance of H.pylori antimicrobial resistance partnership(SHARP)study,1993-1999[J].Ann Intern Med.2002,136(1):13～24.

二级参考文献16

  • 1Dore MP, Leandro G, Realdi G, et al. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy. Dig Dis Sci, 2000, 45 (1): 68-76.
  • 2Megraud Francis. Epidemiology and mechanism of antibiotic resis tance in helicobacter pylori. Gastroenterology, 1998, 115 (5): 1278 12-82.
  • 3Glupezynski Y. Antimicrobial resistance in Helicobacter pylori: a global overview. Acta Gastroenterol Belg, 1998, 61 (3): 357 366.
  • 4Van Zwet AA, Vandenbrouke Grauls CM, Thijs JC, et al. Stable amoxicillin resistance in Helicobacter pylori. Lancet, 1998, 352 (14): 15-95.
  • 5Banatvala N, Davies GR, Abdi Y, et al. High prevalence of Helicobacter pylori metronidazole resistance in migrant to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut, 1994, 35 (11 12): 1562 15-66.
  • 6Lam SK, Talley NJ. Helicobacter pylori consensus: report of the 1997 Asia Pacific consensus conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998, 13 (1): 1-12.
  • 7Van Der Wouden EJ, Thijs JC, Van Zwet AA, et al. Nitroimi dazole resistance in Helicobacter pylori. Alimint Pharmacol Ther,2000, 14 (1): 7-14.
  • 8Ling TK,Cheng AF,Sung JJ,et al.An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study[].Helicobacter.1996
  • 9Vakil N,Hahn B,McSorley D.Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States[].The American journal of Gastroenterology.1998
  • 10全国慢性胃炎研讨会共识意见[J].中华消化杂志,2000,20(3):199-201. 被引量：1124

共引文献167

同被引文献14

  • 1仝佳,刘继斌,邵世和.幽门螺杆菌感染的胃黏膜组织硒含量的检测及其临床意义[J].江苏大学学报（医学版）,2004,14(416):473-475. 被引量：4
  • 2杜鹏,冯伟华,郭俊生.蛋白质组双向电泳技术研究进展[J].卫生研究,2005,34(2):237-240. 被引量：31
  • 3杜光红,陈霞,王忠琼,邓明明,李昌平.三联疗法根除幽门螺杆菌临床观察[J].实用诊断与治疗杂志,2006,20(11):806-808. 被引量：5
  • 4Williamson J S. Helicobacter pylori: current chemotherapy and new targets for drug design[J]. Curr Pharm Des, 2001,7(5): 355- 392.
  • 5Kim J G. Treatment of Helicobacter pylori infection[J]. Korean J Gastroenterol,2005,46(3) : 172-180.
  • 6Sisson G, Jeong J Y, Goodwin A, et al. Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA ( + ) (Nitroreductase) gene [J]. J Bacteriol, 2000,182(18) :5091- 5096.
  • 7Jeong J Y, Mukhopadhyay A K, Akada J K, et al. Roles of FrxA and RdxA nitroreduetases of Helicobacter pylori in susceptibility and resistance to metronidazole[J]. J Bacteriol, 2001,183(17) :5155-5162.
  • 8Marais A, Bilardi C, Cantet F, et al. Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori[J]. Res Microbiol, 2003,154 (2) : 137-144.
  • 9Kwon D H, EI-Zaatari F A, Kato M, et al. Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori[J]. Antimicrob Agents Chemother, 2000, 44(8): 2133-2142.
  • 10Gorg A, Weiss W, Dunn M J. Current two dimensional electrophoresis technology for proteomics [J]. Proteomics,2004,4(12):3665-3685.

引证文献1

二级引证文献2

中外医疗
2007年 第24期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部